Sleep Condition

Sleep Apnea

Sleep apnea is a treatable medical condition where breathing repeatedly stops and starts during sleep. Most people who have it don't know it. The damage isn't from any single event — it's from hundreds of nightly breathing interruptions, repeated over years, accumulating into elevated risk for cardiovascular disease, hypertension, stroke, type 2 diabetes, cognitive decline, and depression.

What sleep apnea is

Sleep apnea is a condition characterized by repeated breathing interruptions during sleep. The most common form — obstructive sleep apnea (OSA) — occurs when the muscles supporting the soft tissue at the back of the throat relax during sleep, allowing the tongue and soft palate to collapse against the airway and block airflow.

Less common forms include central sleep apnea, in which the brain temporarily fails to signal the breathing muscles, and complex (or mixed) sleep apnea, which combines obstructive and central elements. This page focuses on OSA, which accounts for the substantial majority of diagnosed cases.

During an apnea event, breathing stops for at least ten seconds. Blood oxygen levels drop. The brain — sensing the deficit — triggers a brief micro-arousal to restart breathing. The person almost never wakes up enough to remember the event. Then sleep resumes, the cycle repeats, and the body absorbs the cumulative cost of hundreds of these interruptions, every night, for years.

Approximately 30 million American adults are estimated to have OSA. Of those, roughly 80% of moderate-to-severe cases — those most likely to cause meaningful long-term damage — have never been diagnosed or treated.

The apnea event cycle: open airway, collapse, recovery breath 01 — Normal Air flows freely 02 — Collapse O₂ ↓ 10+ sec Breathing stops 03 — Recovery ! arousal Brain triggers gasp ↻ Cycle repeats 5–30+ times per hour, every night
Figure 1. The mechanism of an obstructive sleep apnea event. The damage is cumulative — hundreds of cycles per night, repeated over years.

Symptoms and warning signs

Sleep apnea is unusual among medical conditions because the most reliable warning signs are observed by someone else — typically a bed partner — rather than experienced by the person who has it. The hallmark signs include:

  • Loud, habitual snoring observed by a bed partner
  • Witnessed pauses in breathing during sleep, often followed by a gasp or choking sound
  • Excessive daytime sleepiness, even after a full night in bed
  • Morning headaches that resolve within an hour or two of waking
  • Difficulty concentrating, short-term memory problems, or unexplained irritability
  • Waking up with a dry mouth or sore throat
  • Frequent nighttime urination (nocturia) without an obvious cause

Habitual snoring is present in approximately 90% of people with OSA — but not all snoring indicates apnea. The combination that warrants evaluation is loud snoring plus daytime symptoms, particularly excessive sleepiness or any of the other signs above.

If a bed partner has ever observed you stop breathing or gasp during sleep, that observation alone is sufficient reason to pursue a sleep evaluation, regardless of how you feel during the day.

Causes and risk factors

Several factors increase the likelihood of developing OSA. Some are anatomical and largely fixed; others are modifiable through lifestyle changes.

Fixed risk factors

  • Age — risk rises substantially after 40
  • Family history — first-degree relatives have meaningfully elevated risk
  • Anatomical features — enlarged tonsils or adenoids, recessed jaw, large neck circumference (greater than 17 inches in men, greater than 15 inches in women), nasal obstruction
  • Male sex — men are diagnosed roughly twice as often as women, though women are significantly underdiagnosed
  • Ancestry — higher rates have been observed among Black, Hispanic, and Pacific Islander populations

Modifiable risk factors

  • Elevated BMI — each 10% weight gain is associated with a roughly 30% increase in apnea events on average
  • Alcohol use, particularly in the hours before sleep
  • Smoking
  • Sedative or opioid medications that further relax airway muscles
  • Sleeping on the back (positional component, present in roughly half of OSA patients)

One of the most underrecognized risk transitions in adult medicine is menopause. Postmenopausal women face approximately three times the OSA risk of premenopausal women — a sharp shift driven by hormonal changes that affect upper airway muscle tone and fat distribution. Women whose snoring or daytime sleepiness emerged or worsened around menopause have a particularly strong indication for evaluation.

How sleep apnea is diagnosed

Sleep apnea cannot be reliably diagnosed by symptoms alone. The diagnostic standard is a sleep study, which directly measures breathing events during sleep. Two formats are commonly used:

In-lab polysomnography (PSG)

The most comprehensive option. The patient spends a single night at a sleep center while sensors simultaneously monitor brain activity, eye movements, heart rate, breathing patterns, blood oxygen levels, and limb movements. PSG is preferred when comorbid conditions are suspected — central sleep apnea, REM behavior disorder, narcolepsy, or complex limb movement disorders all require the broader sensor array.

Home sleep test (HSAT)

A smaller device worn at home that monitors breathing, heart rate, and oxygen levels overnight. Clinically validated for moderate-to-severe OSA in adults without significant comorbidities. More convenient, lower cost, and typically returns results within several days. Most insurance plans cover an HSAT as the appropriate first study for uncomplicated suspected OSA.

The Apnea-Hypopnea Index

The diagnosis is based on the Apnea-Hypopnea Index (AHI) — the average number of breathing events per hour of sleep, including both full apneas (complete pauses) and hypopneas (partial blockages with measurable oxygen drop or arousal).

Apnea-Hypopnea Index severity classification Apnea-Hypopnea Index (AHI) — events per hour of sleep 0 5 15 30 + Normal Mild OSA Moderate OSA Severe OSA
Figure 2. AHI severity classification per the American Academy of Sleep Medicine. Treatment is generally indicated at AHI ≥ 5 with daytime symptoms, or AHI ≥ 15 regardless of symptoms.

Treatment is generally indicated for AHI ≥ 5 with daytime symptoms, or AHI ≥ 15 regardless of symptoms. The presence of cardiovascular comorbidities (hypertension, atrial fibrillation, heart failure, prior stroke) lowers the threshold at which treatment is recommended.

Treatment options

OSA is highly treatable. The right approach depends on severity, anatomy, comorbidities, and patient preferences. The options below are presented in approximate order of clinical first-line preference for moderate-to-severe disease.

Typical reduction in apnea events by treatment type Typical AHI reduction by treatment type CPAP (≥4 hrs/night) 80–95% Oral appliance 50–70% Surgery (selected) 50–70% Lifestyle modification 20–40% 0% 50% 100%
Figure 3. Typical efficacy ranges across treatment modalities. Individual outcomes depend on adherence, anatomy, and severity. CPAP outcomes assume consistent ≥4-hour nightly use.

Continuous Positive Airway Pressure (CPAP)

The gold-standard treatment. A bedside machine delivers gentle, continuous positive air pressure through a mask to keep the upper airway open during sleep. When used consistently for at least four hours per night, CPAP reduces apnea events by 80% or more in most patients and substantially reverses the cardiovascular risk associated with untreated OSA. Modern machines are quiet (under 30 decibels), compact, and travel-friendly.

Mask fit is the single most important variable in CPAP success. Most reported "CPAP failures" are actually mask-fit failures — patients who tried one mask style, found it uncomfortable, and discontinued therapy. Three primary mask categories (nasal pillows, nasal masks, full-face masks) accommodate most anatomy and breathing patterns. Working with an experienced respiratory therapist or sleep specialist to find the right mask is well worth the time.

Oral appliance therapy

A custom-fitted dental device worn during sleep that advances the lower jaw slightly, mechanically holding the upper airway open. Effective for mild-to-moderate OSA, typically reducing apnea events by 50–70%. Best fitted by a dentist with formal sleep-medicine training (the field is called dental sleep medicine). Often the right choice for patients who cannot tolerate CPAP, or who travel frequently and need a more portable option.

Lifestyle modification

Several lifestyle changes can meaningfully reduce OSA severity, sometimes substantially:

  • Weight loss — a 10% reduction in body weight can reduce AHI by approximately 25–30% in patients with elevated BMI
  • Positional therapy — for patients whose apnea is significantly worse when sleeping on the back, devices and techniques that promote side-sleeping can substantially help
  • Alcohol moderation, particularly avoiding alcohol in the three hours before bedtime
  • Smoking cessation

Lifestyle changes are usually adjuncts to other treatments rather than standalone solutions for moderate-to-severe disease, but they can shift severity meaningfully and improve outcomes when combined with CPAP or oral appliance therapy.

Surgical and device-based options

Several surgical approaches exist for selected patients who cannot tolerate or do not adequately benefit from CPAP. These include upper airway soft-tissue surgery (UPPP), maxillomandibular advancement (MMA), and implantable hypoglossal nerve stimulators (the Inspire device). Outcomes vary substantially by approach and patient selection. Consultation with a sleep surgeon or sleep specialist with surgical-pathway experience is essential before considering any of these.

What untreated sleep apnea costs

Untreated OSA is associated with significantly elevated risk across multiple organ systems. The relationships are well-established in the clinical literature:

  • Cardiovascular disease — 2–3× higher risk of coronary artery disease and heart failure
  • Hypertension — approximately 50% of patients with treatment-resistant hypertension have undiagnosed OSA; treating OSA reduces blood pressure
  • Stroke — 2–4× higher risk
  • Atrial fibrillation — strong bidirectional relationship; OSA treatment reduces post-ablation AFib recurrence
  • Type 2 diabetes — OSA reduces insulin sensitivity independently of weight
  • Cognitive decline and dementia — accumulating evidence links untreated OSA to elevated dementia risk
  • Depression and anxiety — frequently comorbid; treatment of OSA often improves mood
  • Motor vehicle accidents — 2–7× higher crash risk due to drowsy driving

These are not theoretical risks. The cumulative effect of years of untreated OSA shows up in real medical outcomes. Crucially, many of these elevated risks are partially or fully reversible with consistent treatment over months to years.

When to see a sleep specialist

A sleep evaluation is appropriate if any of the following apply:

  • You snore loudly and habitually, particularly with witnessed breathing pauses
  • You experience excessive daytime sleepiness despite adequate sleep time
  • You have hypertension, especially if it is difficult to control with medication
  • You have atrial fibrillation, type 2 diabetes, heart failure, or have had a stroke
  • You have woken up gasping or choking
  • You experience morning headaches combined with daytime fatigue
  • A bed partner is concerned about your breathing or snoring during sleep

A primary care physician can place a referral, or many sleep centers accept self-referrals directly. A home sleep test can typically be ordered, completed, and reported within one to two weeks. If you've recognized two or more of the above, the next step is straightforward.

Frequently asked questions

How is sleep apnea diagnosed?
Sleep apnea is diagnosed through a sleep study that directly measures breathing events during sleep. Two formats exist: an in-lab polysomnography (the most comprehensive option) or a home sleep test (more convenient and clinically validated for most adults without significant comorbidities). Diagnosis is based on the Apnea-Hypopnea Index, which counts breathing events per hour of sleep.
Can I be tested at home, or do I need to go to a sleep lab?
For most adults with suspected obstructive sleep apnea and no significant heart, lung, or neurological comorbidities, a home sleep test is the appropriate first study. It is convenient, lower cost, and typically returns results within several days. An in-lab polysomnography is preferred when central sleep apnea, REM behavior disorder, narcolepsy, or other complex sleep conditions are suspected, or when the home test results are inconclusive. A sleep specialist can recommend which format is right for your situation.
What is the difference between CPAP and BiPAP?
CPAP delivers a single continuous level of positive air pressure throughout the breathing cycle. BiPAP delivers two pressure levels — a higher pressure during inhalation and a lower pressure during exhalation — which can make breathing feel more natural at high pressure settings. BiPAP is typically used for patients who require very high pressures, who have central or complex sleep apnea, or who cannot tolerate exhaling against the constant pressure of CPAP. The choice between CPAP and BiPAP is made in consultation with a sleep specialist based on the sleep study results.
Will losing weight cure my sleep apnea?
Weight loss can substantially reduce the severity of sleep apnea in patients with elevated BMI. A 10% reduction in body weight is associated with approximately a 25 to 30 percent reduction in apnea events on average. For some patients with mild OSA driven primarily by weight, sufficient weight loss can be effectively curative. For most patients with moderate-to-severe OSA, weight loss is an important adjunct to treatment but typically does not eliminate the condition entirely. A repeat sleep study after significant weight loss can confirm whether ongoing treatment is still needed.
Is sleep apnea hereditary?
There is a meaningful hereditary component. First-degree relatives of patients with obstructive sleep apnea have approximately twice the risk of developing the condition compared to the general population. The inherited contribution comes through anatomical features (face and airway structure), tendencies in fat distribution, and ventilatory control patterns. Genetics is one factor among several — lifestyle, anatomical, and demographic factors all play substantial roles.
How quickly does treatment improve symptoms?
Most patients notice meaningful improvements in daytime energy, mental clarity, and mood within two to four weeks of consistent CPAP or oral appliance therapy. Morning headaches and waking unrefreshed often resolve within the first several days. Cardiovascular benefits — including blood pressure reduction, reduced atrial fibrillation recurrence, and improved cardiac function — accumulate over months to years of consistent treatment.
Can children have sleep apnea?
Yes. Pediatric obstructive sleep apnea is more common than most parents realize and presents differently than adult OSA. Rather than excessive sleepiness, children with sleep apnea often appear hyperactive, inattentive, and emotionally dysregulated. The most common cause in children is enlarged tonsils and adenoids; a tonsillectomy and adenoidectomy is often curative. Loud habitual snoring in a child is the most reliable warning sign and warrants pediatric sleep evaluation.

Talk to a board-certified sleep specialist near you.

🌙
Ask Sleepi™
AI
🌙
Sleepi™
AI Sleep Guide
🌙
Hi! I am Sleepi™, your AI sleep guide. Ask me anything about sleep disorders, symptoms, or treatments!